Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 5, 2006, Pages 736-745

  Wang, Yigang ^a   Haider, Husnain K ^a   Ahmad, Nauman ^a   Xu, Meifeng ^a   Ge, Ruowen ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Bone marrow stem cells; Cytokines; Heart infarction; Myocyte regeneration

Indexed keywords

CYTOKINE; SODIUM CHLORIDE; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BONE MARROW CELL; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DENSITY; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTILITY; IMMUNOHISTOLOGY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; HEART VENTRICLES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS MUSCULUS;

EID: 33646100313     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.02.004     Document Type: Article

References (33)

1. Eisenberg L.M., Burns L., and Eisenberg C.A. Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro. Anat. Rec. 274A (2003) 870-882
2. Chiu R.C. Bone-marrow stem cells as a source for cell therapy. Heart Fail. Rev. 8 (2003) 247-251
3. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98 (2001) 10344-10349
4. Bodine D.M., Seidel N.E., and Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88 (1996) 89-97
5. Takano H., Ohtsuka M., Akazawa H., Toko H., Harada M., Hasegawa H., et al. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr. Pharm. Des. 9 (2003) 1121-1127
6. Mardiney M., and Malech H.L. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy. Blood 87 (1996) 4049-4056
7. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., and Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci. 938 (2001) 221-229
8. Kinnaird T., Stabile E., Epstein S.E., and Fuchs S. Current perspectives in therapeutic myocardial angiogenesis. J. Interv. Cardiol. 16 (2003) 289-297
9. Haider H., Ye L., Jiang S., Ge R., Law P.K., Chua T., et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J. Mol. Med. 82 (2004) 539-549
10. Matsumoto R., Omura T., Yoshiyama M., Hayashi T., Inamoto S., Koh K.R., et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1168-1173
11. Kudo M., Wang Y., Wani M.A., Xu M., Ayub A., and Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 35 (2003) 1113-1119
12. Haas S.J., Bauer P., Rolfs A., and Wree A. Immunocytochemical characterization of in vitro PKH26-labelled and intracerebrally transplanted neonatal cells. Acta Histochem. 102 (2000) 273-280
13. Kuramochi Y. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr. Res. 54 (2003) 319-325
14. Wang Y., Ahmad N., Wani M.A., and Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 37 (2004) 1041-1052
15. Noach E.J., Ausema A., Dillingh J.H., Dontje B., Weersing E., Akkerman I., et al. Growth factor treatment prior to low-dose total body irradiation increases donor cell engraftment after bone marrow transplantation in mice. Blood 100 (2002) 312-317
16. Wright D.E., Edward P., Bowman E.P., Wagers A.J., Butcher E.C., and Weissman I.L. Hematopoietic Stem Cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195 (2002) 1145-1154
17. Reyes M., Freeman G.L., Escobedo D., Lee S., Steinhelper M.E., and Feldman M.D. Enhancement of contractility with sustained afterload in the intact murine heart: blunting of length-dependent activation. Circulation 107 (2003) 2962-2968
18. Broudy V.C. Stem cell factor and hematopoiesis. Blood 90 (1997) 1345-1364
19. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
20. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., and Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci. 938 (2001) 221-229
21. Scholzen T., and Gerdes J. The ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182 (2000) 311-322
22. Lei Y., Haider H., Shujia J., and Sim E.S. Therapeutic angiogenesis. Devising new strategies based on past experiences. Basic Res. Cardiol. 99 (2004) 121-132
23. Yau T.M., Li G., Weisel R.D., Reheman A., Jia Z.Q., Mickle D.A., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J. Thorac. Cardiovasc. Surg. 127 (2004) 1180-1187
24. Meharwal Z.S., Mishra A., and Trehan N. Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy. Ann. Thorac. Surg. 73 (2002) 793-797
25. Mukherjee D. Optimizing management of patients with coronary artery disease: how do we get there?. Eur. Heart J. 26 (2005) 1147-1149
26. Hammond H.K., and McKirnan M.D. Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials. Cardiovasc. Res. 49 (2001) 561-567
27. Freedman S.B., and Isner J.M. Therapeutic angiogenesis for coronary artery disease. Ann. Intern. Med. 136 1 (2002) 54-71
28. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95 (2004) 9-20
29. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
30. Woldbaek P.R., Hoen I.B., Christensen G., and Tonnessen T. Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol. Scand. 175 (2002) 173-181
31. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., et al. 2001. Plasma elevation of stromal derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
32. Kawamoto A., Murayama T., Kusano K., Ii M., Tkebuchava T., Shintani S., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
33. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438